跳至主要内容
临床试验/NCT02777164
NCT02777164终止不适用

Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer

Real Imaging Ltd.2 个研究点 分布在 1 个国家目标入组 740 人开始时间: 2016年5月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
740
试验地点
2
主要终点
The difference in the area under the ROC curve (AUC) of mammography plus MIRA compared to mammography alone.

研究概览

简要总结

The objective of the study is to estimate the diagnostic accuracy of cancer detection when MIRA technology is combined with mammography, by evaluating the area under the ROC curve (AUC) of mammography vs. mammography plus MIRA. This evaluation will be done in a Reader Study on a subset of women with histology confirmed cancer and healthy women with dense breast.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • A. Subjects who are asymptomatic and scheduled to undergo routine screening mammography
  • B. Subjects scheduled for image guided needle biopsy as a result of findings obtained during standard of care imaging modalities
  • C. Subjects has a prior mammogram and have been diagnosed with extremely or heterogeneously dense breast tissue (Density C or D)

排除标准

  • Male by birth.
  • Individual is less than 30 and greater than 70 years old.
  • Contraindication to bilateral mammography or MRI
  • Subjects who are unable to read, understand and execute the informed consent procedure.
  • Subjects who have had mammography ultrasound or MRI examination performed on the day of the study prior to MIRA scan.
  • Subjects who have significant existing breast trauma.
  • Subjects who have undergone lumpectomy/mastectomy.
  • Subjects who have undergone breast reduction or breast augmentation.
  • Subjects who have undergone any other type of breast surgery, excluding surgical biopsy.
  • Subjects who have large breast scar / Breast deformation
  • Subjects who have undergone a breast needle biopsy or a surgical biopsy within the 6 month period prior to their intended enrollment into the study.
  • Subjects who have a temperature > 100° F (37.8C) degrees on the day of the MIRA imaging
  • Subjects who are pregnant or lactating
  • Subjects with known Raynaud's Disease
  • Subjects that are claustrophobic or have physical limitations that do allow them to sit in the system chair for the required imaging session.
  • Subjects with implanted pacemaker/defibrillator, implanted venous access device (portacath) or other implanted devices
  • Subject with kidney failure
  • Subject with known allergy to gadolinium
  • Subject with a history of multiple contrast MRI scans (more than 4 MRI scans over the past two year)
  • Inmates (45 CFR 46.306) or mentally disabled individuals
  • Subjects with a BI-RADS category 6 (e.g. for which mammogram was performed for the purpose of planning cancer therapy)
  • Subjects currently participating in another investigational clinical study
  • Subjects who participated in the Calibration Phase will not be able to participate in the Testing Phase

研究组 & 干预措施

MIRA device imaging

Experimental

MIRA Device imaging for adjunctive detection of breast cancer

干预措施: MIRA device imaging (Device)

结局指标

主要结局

The difference in the area under the ROC curve (AUC) of mammography plus MIRA compared to mammography alone.

时间窗: 19 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验